Close

BioTime, Inc. Announces Closing of Public Offering and Underwriters’ Full Exercise of Over-Allotment Option Oct 17, 2017 04:05PM
Asterias Biotherapeutics Announces $10.4 Million Registered Direct Offering Oct 16, 2017 08:30AM
BioTime (BTX) Prices 9.6M Share Common Offering at $2.60/Sh Oct 13, 2017 09:17AM
BioTime, Inc. Announces Pricing of $25.0 Million Public Offering of Common Stock Oct 13, 2017 09:15AM
BioTime, Inc. Announces Closing of Public Offering of Common Stock Feb 15, 2017 04:05PM


Feb 10, 2017 09:03AM BioTime (BTX) Prices 6.5M Common Stock Offering at $2.70/Share
Feb 10, 2017 09:02AM BioTime, Inc. Announces Pricing of Public Offering of Common Stock
Jul 5, 2016 11:35AM BioTime, Inc. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option
Jun 21, 2016 11:55AM BioTime, Inc. Announces Closing of Public Offering of Common Stock
Jun 16, 2016 09:56AM BioTime (BTX) Prices 7.3M Stock Offering at $2.39/Share
Jun 16, 2016 09:41AM BioTime, Inc. Announces Pricing of Public Offering of Common Stock
Feb 19, 2016 07:34AM Chardan Capital Markets Starts BioTime, Inc. (BTX) at Buy
Jul 15, 2015 08:30AM OncoCyte Announces Appointment of Andy Arno to Board of Directors